BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25385285)

  • 1. Effect of ulinastatin on the expression and distribution of high mobility group box 1 in human colon carcinoma cells in vitro.
    Wang Y; Tao T; Dong Y; Zhang J; Qin Z
    Mol Med Rep; 2015 Mar; 11(3):2041-7. PubMed ID: 25385285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.
    Völp K; Brezniceanu ML; Bösser S; Brabletz T; Kirchner T; Göttel D; Joos S; Zörnig M
    Gut; 2006 Feb; 55(2):234-42. PubMed ID: 16118352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group protein B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-κB.
    Chai Y; Xiao J; Zhang S; Du Y; Luo Z; Zhou X; Huang K
    Int J Mol Med; 2018 Mar; 41(3):1651-1658. PubMed ID: 29328447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway.
    Liu Q; Huo Y; Zheng H; Zhao J; Jia L; Wang P
    Oncol Rep; 2019 Aug; 42(2):817-825. PubMed ID: 31173265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
    Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
    Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
    Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
    Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells].
    Li ZJ; Song B; Liu J; Han JJ; Wang CX; Zhu YX; Xu ZF
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):244-8. PubMed ID: 23985250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB.
    Wang H; Sun X; Gao F; Zhong B; Zhang YH; Sun Z
    J Exp Clin Cancer Res; 2012 Jan; 31(1):2. PubMed ID: 22217202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
    Zhu L; Li X; Chen Y; Fang J; Ge Z
    Cancer Lett; 2015 Feb; 357(2):527-34. PubMed ID: 25511739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells].
    Yu Y; Xie M; He YL; Xu WQ; Zhu S; Cao LZ
    Ai Zheng; 2008 Sep; 27(9):929-33. PubMed ID: 18799030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells.
    Song B; Song WG; Li ZJ; Xu ZF; Wang XW; Wang CX; Liu J
    Cell Biochem Funct; 2012 Jan; 30(1):11-7. PubMed ID: 21953494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effects of high mobility group box 1 antisense nucleotide on invasion of human pancreatic cancer cell line PCNA-1].
    Huang QX; Wang GB; Sun NF; Wang CY
    Ai Zheng; 2004 Sep; 23(9):1036-40. PubMed ID: 15363197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
    Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
    Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
    Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
    Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells.
    Wang Z; Wang X; Li J; Yang C; Xing Z; Chen R; Xu F
    Mol Med Rep; 2016 Jul; 14(1):1026-32. PubMed ID: 27220399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effects on cell proliferation and motility in gastric cancer SGC-7901 cells by introducing ulinastatin in vitro.
    Wang J; Chen X; Su L; Zhu Z; Wu W; Zhou Y
    Anticancer Drugs; 2016 Aug; 27(7):651-9. PubMed ID: 27187019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction.
    Jiang GT; Chen X; Li D; An HX; Jiao JD
    Mol Med Rep; 2014 Sep; 10(3):1501-8. PubMed ID: 24926571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers.
    Sun ZJ; Yu T; Chen JS; Sun X; Gao F; Zhao XL; Luo J
    J Int Med Res; 2010; 38(3):967-76. PubMed ID: 20819433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.